ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ILU - US4523271090 - Common Stock
122.74 EUR
+4.58 (+3.88%)
We assign a fundamental rating of 6 out of 10 to ILU. ILU was compared to 22 industry peers in the Life Sciences Tools & Services industry. ILU has an excellent profitability rating, but there are some minor concerns on its financial health. ILU has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year ILU was profitable.
In the past year ILU had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ILU reported negative net income in multiple years.
In the past 5 years ILU always reported a positive cash flow from operatings.
1.2 Ratios
ILU has a Return On Assets of 11.38%. This is amongst the best in the industry. ILU outperforms 90.91% of its industry peers.
Looking at the Return On Equity, with a value of 29.53%, ILU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ILU has a Return On Invested Capital of 14.61%. This is amongst the best in the industry. ILU outperforms 90.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROIC | 14.61% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ILU has a Profit Margin of 16.39%. This is amongst the best in the industry. ILU outperforms 81.82% of its industry peers.
With an excellent Operating Margin value of 20.41%, ILU belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
In the last couple of years the Operating Margin of ILU has declined.
The Gross Margin of ILU (66.74%) is better than 95.45% of its industry peers.
ILU's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ILU is creating some value.
Compared to 1 year ago, ILU has about the same amount of shares outstanding.
ILU has more shares outstanding than it did 5 years ago.
ILU has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.64 indicates that ILU is not in any danger for bankruptcy at the moment.
ILU has a better Altman-Z score (4.64) than 72.73% of its industry peers.
The Debt to FCF ratio of ILU is 1.99, which is an excellent value as it means it would take ILU, only 1.99 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ILU (1.99) is better than 100.00% of its industry peers.
ILU has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
ILU has a Debt to Equity ratio of 0.42. This is in the better half of the industry: ILU outperforms 77.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Altman-Z | 4.64 |
ROIC/WACC1.37
WACC10.66%
2.3 Liquidity
A Current Ratio of 1.43 indicates that ILU should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.43, ILU is in line with its industry, outperforming 50.00% of the companies in the same industry.
ILU has a Quick Ratio of 1.12. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
ILU has a Quick ratio of 1.12. This is in the better half of the industry: ILU outperforms 68.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 152.02% over the past year.
Measured over the past years, ILU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.93% on average per year.
Looking at the last year, ILU shows a decrease in Revenue. The Revenue has decreased by -2.32% in the last year.
The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
3.2 Future
The Earnings Per Share is expected to grow by 24.49% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.93% on average over the next years.
EPS Next Y96.03%
EPS Next 2Y44.64%
EPS Next 3Y34.05%
EPS Next 5Y24.49%
Revenue Next Year-0.86%
Revenue Next 2Y0.68%
Revenue Next 3Y2.56%
Revenue Next 5Y3.93%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ILU is valuated quite expensively with a Price/Earnings ratio of 33.08.
ILU's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.17, ILU is valued a bit more expensive.
ILU is valuated quite expensively with a Price/Forward Earnings ratio of 28.14.
ILU's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of ILU to the average of the S&P500 Index (23.79), we can say ILU is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.08 | ||
| Fwd PE | 28.14 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ILU indicates a somewhat cheap valuation: ILU is cheaper than 63.64% of the companies listed in the same industry.
ILU's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ILU is cheaper than 77.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.04 | ||
| EV/EBITDA | 19.58 |
4.3 Compensation for Growth
ILU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ILU has a very decent profitability rating, which may justify a higher PE ratio.
ILU's earnings are expected to grow with 34.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y44.64%
EPS Next 3Y34.05%
5. Dividend
5.1 Amount
ILU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:ILU (1/6/2026, 7:00:00 PM)
122.74
+4.58 (+3.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.7%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap18.75B
Revenue(TTM)4.29B
Net Income(TTM)703.00M
Analysts72.86
Price Target107.33 (-12.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)3.51%
PT rev (3m)9.76%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)3.08%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)4.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.08 | ||
| Fwd PE | 28.14 | ||
| P/S | 5.14 | ||
| P/FCF | 22.04 | ||
| P/OCF | 19.64 | ||
| P/B | 9.26 | ||
| P/tB | 21.13 | ||
| EV/EBITDA | 19.58 |
EPS(TTM)3.71
EY3.02%
EPS(NY)4.36
Fwd EY3.55%
FCF(TTM)5.57
FCFY4.54%
OCF(TTM)6.25
OCFY5.09%
SpS23.88
BVpS13.26
TBVpS5.81
PEG (NY)0.34
PEG (5Y)N/A
Graham Number33.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROCE | 20.76% | ||
| ROIC | 14.61% | ||
| ROICexc | 20.97% | ||
| ROICexgc | 38.52% | ||
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% | ||
| FCFM | 23.32% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 44.36% | ||
| Cap/Sales | 2.85% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.57% | ||
| Profit Quality | 142.25% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 4.64 |
F-Score7
WACC10.66%
ROIC/WACC1.37
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y96.03%
EPS Next 2Y44.64%
EPS Next 3Y34.05%
EPS Next 5Y24.49%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-0.86%
Revenue Next 2Y0.68%
Revenue Next 3Y2.56%
Revenue Next 5Y3.93%
EBIT growth 1Y154.36%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year36.79%
EBIT Next 3Y17.14%
EBIT Next 5Y16.22%
FCF growth 1Y495.24%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y179.8%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%
ILLUMINA INC / ILU.DE FAQ
What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE.
What is the valuation status for ILU stock?
ChartMill assigns a valuation rating of 5 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.
How profitable is ILLUMINA INC (ILU.DE) stock?
ILLUMINA INC (ILU.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for ILU stock?
The financial health rating of ILLUMINA INC (ILU.DE) is 6 / 10.